IOVANCE BIOTHERAPEUTICS, INC. - IOVA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 03, 2026 | Interim CEO & General Counsel | M | D | 41,668.0 | 0.0 | 0.0 | 125,007.0 | View | |
| Jun 03, 2026 | Interim CEO & General Counsel | F | D | 17,701.0 | 3.96 | 70,095.96 | 553,505.0 | View | |
| Jun 03, 2026 | Interim CEO & General Counsel | M | A | 41,668.0 | 0.0 | 0.0 | 571,206.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | M | D | 5,469.0 | 0.0 | 0.0 | 16,409.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | F | D | 2,508.0 | 3.96 | 9,931.68 | 242,191.0 | View | |
| Jun 03, 2026 | Chief Regulatory Officer | M | A | 5,469.0 | 0.0 | 0.0 | 244,699.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | M | D | 8,790.0 | 0.0 | 0.0 | 26,369.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | F | D | 4,473.0 | 3.96 | 17,713.08 | 136,274.0 | View | |
| Jun 03, 2026 | Chief Medical Officer | M | A | 8,790.0 | 0.0 | 0.0 | 140,747.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | M | D | 8,790.0 | 0.0 | 0.0 | 26,369.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | F | D | 4,473.0 | 3.96 | 17,713.08 | 130,083.0 | View | |
| Jun 03, 2026 | Chief Operating Officer | M | A | 8,790.0 | 0.0 | 0.0 | 134,556.0 | View | |
| May 13, 2026 | Chief Commercial Officer | M | D | 10,000.0 | 0.0 | 0.0 | 70,004.0 | View | |
| May 13, 2026 | Chief Commercial Officer | F | D | 2,435.0 | 3.7 | 9,009.5 | 146,946.0 | View | |
| May 13, 2026 | Chief Commercial Officer | M | A | 10,000.0 | 0.0 | 0.0 | 149,381.0 | View | |
| Mar 11, 2026 | Chief Operating Officer | A | A | 117,500.0 | 0.0 | 0.0 | 117,500.0 | View | |
| Mar 11, 2026 | Chief Commercial Officer | A | A | 132,200.0 | 0.0 | 0.0 | 132,200.0 | View | |
| Mar 11, 2026 | Chief Medical Officer | A | A | 58,750.0 | 0.0 | 0.0 | 58,750.0 | View | |
| Mar 11, 2026 | Chief Regulatory Officer | A | A | 117,500.0 | 0.0 | 0.0 | 117,500.0 | View | |
| Mar 11, 2026 | Interim CEO & General Counsel | A | A | 235,000.0 | 0.0 | 0.0 | 235,000.0 | View | |
| Mar 11, 2026 | Chief Financial Officer | A | A | 132,200.0 | 0.0 | 0.0 | 132,200.0 | View | |
| Mar 06, 2026 | Chief Regulatory Officer | M | D | 39,059.0 | 0.0 | 0.0 | 78,131.0 | View | |
| Mar 06, 2026 | Chief Regulatory Officer | F | D | 18,360.0 | 4.58 | 84,088.8 | 239,230.0 | View | |
| Mar 06, 2026 | Chief Regulatory Officer | M | A | 39,059.0 | 0.0 | 0.0 | 257,590.0 | View | |
| Mar 06, 2026 | Chief Medical Officer | M | D | 31,246.0 | 0.0 | 0.0 | 62,504.0 | View | |
| Mar 06, 2026 | Chief Medical Officer | F | D | 16,520.0 | 4.58 | 75,661.6 | 131,957.0 | View | |
| Mar 06, 2026 | Chief Medical Officer | M | A | 31,246.0 | 0.0 | 0.0 | 148,477.0 | View | |
| Mar 06, 2026 | Interim CEO & General Counsel | M | D | 62,493.0 | 0.0 | 0.0 | 125,007.0 | View | |
| Mar 06, 2026 | Interim CEO & General Counsel | F | D | 26,755.0 | 4.58 | 122,537.9 | 529,538.0 | View | |
| Mar 06, 2026 | Interim CEO & General Counsel | M | A | 62,493.0 | 0.0 | 0.0 | 556,293.0 | View | |
| Mar 06, 2026 | Chief Operating Officer | M | D | 31,246.0 | 0.0 | 0.0 | 62,504.0 | View | |
| Mar 06, 2026 | Chief Operating Officer | F | D | 16,628.0 | 4.58 | 76,156.24 | 125,766.0 | View | |
| Mar 06, 2026 | Chief Operating Officer | M | A | 31,246.0 | 0.0 | 0.0 | 142,394.0 | View | |
| Mar 04, 2026 | Chief Regulatory Officer | M | D | 5,470.0 | 0.0 | 0.0 | 21,878.0 | View | |
| Mar 04, 2026 | Chief Regulatory Officer | F | D | 2,798.0 | 3.79 | 10,604.42 | 218,531.0 | View | |
| Mar 04, 2026 | Chief Regulatory Officer | M | A | 5,470.0 | 0.0 | 0.0 | 221,329.0 | View | |
| Mar 04, 2026 | Chief Operating Officer | M | D | 3,517.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 04, 2026 | Chief Operating Officer | M | D | 8,790.0 | 0.0 | 0.0 | 35,159.0 | View | |
| Mar 04, 2026 | Chief Operating Officer | F | D | 6,903.0 | 3.79 | 26,162.37 | 111,148.0 | View | |
| Mar 04, 2026 | Chief Operating Officer | M | A | 12,307.0 | 0.0 | 0.0 | 118,051.0 | View | |
| Mar 04, 2026 | Interim CEO & General Counsel | M | D | 10,418.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 04, 2026 | Interim CEO & General Counsel | M | D | 41,669.0 | 0.0 | 0.0 | 166,675.0 | View | |
| Mar 04, 2026 | Interim CEO & General Counsel | F | D | 22,809.0 | 3.79 | 86,446.11 | 493,800.0 | View | |
| Mar 04, 2026 | Interim CEO & General Counsel | M | A | 52,087.0 | 0.0 | 0.0 | 516,609.0 | View | |
| Mar 04, 2026 | Chief Medical Officer | M | D | 3,907.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 04, 2026 | Chief Medical Officer | M | D | 8,790.0 | 0.0 | 0.0 | 35,159.0 | View | |
| Mar 04, 2026 | Chief Medical Officer | F | D | 7,122.0 | 3.79 | 26,992.38 | 117,231.0 | View | |
| Mar 04, 2026 | Chief Medical Officer | M | A | 12,697.0 | 0.0 | 0.0 | 124,353.0 | View | |
| Feb 26, 2026 | Chief Commercial Officer | M | D | 150,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 26, 2026 | Chief Commercial Officer | F | D | 34,165.0 | 3.78 | 129,143.7 | 139,381.0 | View | |
| Feb 26, 2026 | Chief Commercial Officer | M | A | 120,000.0 | 0.0 | 0.0 | 173,546.0 | View | |
| Feb 12, 2026 | Chief Commercial Officer | M | D | 39,996.0 | 0.0 | 0.0 | 80,004.0 | View | |
| Feb 12, 2026 | Chief Commercial Officer | F | D | 16,450.0 | 2.6 | 42,770.0 | 53,546.0 | View | |
| Feb 12, 2026 | Chief Commercial Officer | M | A | 39,996.0 | 0.0 | 0.0 | 69,996.0 | View |